Vimovo is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Horizon Therapeutics Usa, Inc.. The primary component is Naproxen; Esomeprazole Magnesium.
Product ID | 75987-030_141883fd-85e4-4d33-afe8-8af811700939 |
NDC | 75987-030 |
Product Type | Human Prescription Drug |
Proprietary Name | Vimovo |
Generic Name | Naproxen And Esomeprazole Magnesium |
Dosage Form | Tablet, Delayed Release |
Route of Administration | ORAL |
Marketing Start Date | 2010-07-06 |
Marketing Category | NDA / NDA |
Application Number | NDA022511 |
Labeler Name | Horizon Therapeutics USA, Inc. |
Substance Name | NAPROXEN; ESOMEPRAZOLE MAGNESIUM |
Active Ingredient Strength | 500 mg/1; mg/1 |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC],Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA],Cytochrome P450 2C19 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2010-07-06 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA022511 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-07-06 |
Marketing Category | NDA |
Application Number | NDA022511 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2010-07-06 |
Ingredient | Strength |
---|---|
NAPROXEN | 500 mg/1 |
SPL SET ID: | baa47781-7151-4c75-a9a2-d2eac0a7d55e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
UPC Code | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
75987-030 | Vimovo | Naproxen and Esomeprazole Magnesium |
75987-031 | Vimovo | Naproxen and Esomeprazole Magnesium |
0378-4385 | Naproxen and Esomeprazole Magnesium | naproxen and esomeprazole magnesium |
0378-4386 | Naproxen and Esomeprazole Magnesium | naproxen and esomeprazole magnesium |
27241-202 | Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium |
27241-203 | Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium |
55111-289 | Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium |
55111-701 | Naproxen and esomeprazole magnesium | Naproxen and esomeprazole magnesium |
70748-215 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
70748-216 | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM | NAPROXEN AND ESOMEPRAZOLE MAGNESIUM |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
VIMOVO 77726998 3914867 Dead/Cancelled |
AstraZeneca UK Limited 2009-05-01 |
VIMOVO 77670350 3941225 Live/Registered |
AstraZeneca UK Limited 2009-02-13 |
VIMOVO 77475260 not registered Dead/Abandoned |
AstraZeneca UK Limited 2008-05-15 |
VIMOVO 75809739 2629729 Dead/Cancelled |
Zeneca Limited 1999-09-28 |